Extracellular matrix as a driver of progressive fibrosis
Authors:
- Jeremy HerreraJHJeremy Herrera
- Craig A. HenkeCHCraig A. Henke
- Peter B. BittermanPBPeter B. Bitterman
Top Cited Papers
Open Access
- 2 January 2018
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (1) , 45-53
Abstract
The extracellular matrix (ECM) is dynamically tuned to optimize physiological function. Its major properties, including composition and mechanics, profoundly influence cell biology. Cell-ECM interactions operate through an integrated set of sensor and effector circuits that use several classes of receptors and signal transduction pathways. At the single-cell level, the ECM governs differentiation, metabolism, motility, orientation, proliferation, and survival. At the cell population level, the ECM provides higher-order guidance that is essential for physiological function. When pathological changes in the ECM lead to impairment of organ function, we use the term “fibrosis.” In this Review, we differentiate fibrosis initiation from progression and focus primarily on progressive lung fibrosis impairing organ function. We present a working model to explain how the altered ECM is not only a consequence but also a driver of fibrosis. Additionally, we advance the concept that fibrosis progression occurs in a fibrogenic niche that is composed of a fibrogenic ECM that nurtures fibrogenic mesenchymal progenitor cells and their fibrogenic progeny.Keywords
This publication has 108 references indexed in Scilit:
- FoxO3a (Forkhead Box O3a) Deficiency Protects Idiopathic Pulmonary Fibrosis (IPF) Fibroblasts from Type I Polymerized Collagen Matrix-Induced Apoptosis via Caveolin-1 (cav-1) and FasPLOS ONE, 2013
- Pulmonary fibrosis: patterns and perpetratorsJournal of Clinical Investigation, 2012
- A Novel Zebrafish Embryo Xenotransplantation Model to Study Primary Human Fibroblast Motility in Health and DiseaseZebrafish, 2012
- Hepatic stellate cells require a stiff environment for myofibroblastic differentiationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44Journal of Experimental Medicine, 2011
- Balancing forces: architectural control of mechanotransductionNature Reviews Molecular Cell Biology, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Liver stiffness: a novel parameter for the diagnosis of liver diseaseHepatic Medicine: Evidence and Research, 2010
- Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosisJournal of Experimental Medicine, 2008
- Fibroblast Foci Are Not Discrete Sites of Lung Injury or RepairAmerican Journal of Respiratory and Critical Care Medicine, 2006